Question 1

What is the catalog number for 50X TAE Buffer (Tris-Acetate-EDTA)?

Accepted Answer

The catalog number for 50X TAE Buffer (Tris-Acetate-EDTA) is CH117.

Question 2

What sizes are available for 50X TAE Buffer (Tris-Acetate-EDTA)?

Accepted Answer

50X TAE Buffer (Tris-Acetate-EDTA) is available in the following size(s): 500 mL.

Question 3

Is 50X TAE Buffer (Tris-Acetate-EDTA) in stock?

Accepted Answer

50X TAE Buffer (Tris-Acetate-EDTA) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is 50X TAE Buffer (Tris-Acetate-EDTA) used for?

Accepted Answer

TAE Buffer is suitable for both horizontal and vertical polyacrylamide gels. May be used in nondenatured and denatured DNA and nondenatured RNA. Unlike TBE, it does not interfere with downstream enzymes such as ligases.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 7

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

50X TAE Buffer (Tris-Acetate-EDTA)

Product Specifications

Concentration

Components

Shipping Conditions

Storage Conditions

Grade

Frequently Asked Questions

Explore Other Products

CD34 (ICO-115), CF640R conjugate, 0.1mg/mL

Cytokeratin, HMW (AE-3), CF594 conjugate, 0.1mg/mL

P34 / cdk1 (POH-1), CF647 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, 0.1mg/mL

CD8 (C8/468), CF568 conjugate, 0.1mg/mL

CD43 (84-3C1), Biotin conjugate, 0.1mg/mL